Short answer
Inhibrx Biosciences, Inc. (INBX) filed an 8-K current report with the SEC on September 28, 2026 reporting Item 7.01 (Regulation FD Disclosure). Updated corporate presentation posted September 28, 2026, signaling refreshed investor messaging.
Inhibrx Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Updated corporate presentation posted September 28, 2026, signaling refreshed investor messaging
- Presentation likely summarizes current business updates for conferences and investor meetings
- Investors should review Exhibit 99.1 for substantive pipeline, clinical, or corporate developments
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Inhibrx Biosciences, Inc. 8-K filings
Get the next INBX 8-K as it lands
Follow INBX for push alerts, or ask the research agent what this filing means.